[Drug resistance analysis of staphylococcus infection in our hospital from 2003 to 2005].
OBJECTIVE
To explore the change in mobility of staphylococcus and its drug resistance etiology investigation and clinical treatment.


METHODS
The routine biochemical identification was used for staphylococcus differentiation. Minimal inhibitory concentrations was used for drug-resistance determination. Some drug-resistance determination were detected by K-B method. The inducible resistance of erythromycin to clindamycin was checked by D-test.


RESULTS
Staphylococcus was in the first place in the hospital infection. The rates of methicillin-resistant staphylococcus were 54.1%. The drug-resistance rates of staphylococcus to penicillin, oxacillin, erythromycin, tetracycline, ciprofloxacin, gentamicin, clindamycin, SMZCO, chloramphenicol, vancomycin, teicoplanin antibacterials were 93.2%, 54.1%, 85.1%, 56.7%, 45.9%, 48.6%, 58.1%. 45.9%, 31.1%, 0%, 0%. D-test positive rate was 37.9%.


CONCLUSIONS
The results are helpful in study of pathogenic bacteria and drug resistance characteristics in staphylococcus infection.
Du
Shui-guo
SG
Department of Clinical Laboratory, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Chinese Peking Union Medical College, Beijing.
Lin
Yu
Y
Wang
Xiao-dong
XD
Wu
Li
L
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003428:Cross Infection / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D019651:Plastic Surgery Procedures; D013203:Staphylococcal Infections / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects* / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents